Schmitt D, Funk N, Blum R, Asan E, Andersen L, Rülicke T, et al. Initial characterization of a Syap1 knock-out mouse and distribution of Syap1 in mouse brain and cultured motoneurons. Histochem Cell Biol. 2016;146:489-512 pubmed publisher

Zhou F, Gao S, Wang L, Sun C, Chen L, Yuan P, et al. Human adipose-derived stem cells partially rescue the stroke syndromes by promoting spatial learning and memory in mouse middle cerebral artery occlusion model. Stem Cell Res Ther. 2015;6:92 pubmed publisher

Kramann N, Menken L, Pförtner R, Schmid S, Stadelmann C, Wegner C, et al. Glial fibrillary acidic protein expression alters astrocytic chemokine release and protects mice from cuprizone-induced demyelination. Glia. 2019;67:1308-1319 pubmed publisher

Boeddrich A, Babila J, Wiglenda T, Diez L, Jacob M, Nietfeld W, et al. The Anti-amyloid Compound DO1 Decreases Plaque Pathology and Neuroinflammation-Related Expression Changes in 5xFAD Transgenic Mice. Cell Chem Biol. 2019;26:109-120.e7 pubmed publisher

Lang D, Schott B, van Ham M, Morton L, Kulikovskaja L, Herrera Molina R, et al. Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition. J Neuroinflammation. 2018;15:216 pubmed publisher

Adolf A, Leondaritis G, Rohrbeck A, Eickholt B, Just I, Ahnert Hilger G, et al. The intermediate filament protein vimentin is essential for axonotrophic effects of Clostridium botulinum C3 exoenzyme. J Neurochem. 2016;139:234-244 pubmed publisher

Kumar S, Wirths O, Stüber K, Wunderlich P, Koch P, Theil S, et al. Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity. Acta Neuropathol. 2016;131:525-37 pubmed publisher

Ganau M, Bosco A, Palma A, Corvaglia S, Parisse P, Fruk L, et al. A DNA-based nano-immunoassay for the label-free detection of glial fibrillary acidic protein in multicell lysates. Nanomedicine. 2015;11:293-300 pubmed publisher

Regus Leidig H, Atorf J, Feigenspan A, Kremers J, Maw M, Brandstätter J. Photoreceptor degeneration in two mouse models for congenital stationary night blindness type 2. PLoS ONE. 2014;9:e86769 pubmed publisher

Segatto M, Manduca A, Lecis C, Rosso P, Jozwiak A, Swiezewska E, et al. Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats. Neuropsychopharmacology. 2014;39:841-54 pubmed publisher

Bruck W, Pförtner R, Pham T, Zhang J, Hayardeny L, Piryatinsky V, et al. Reduced astrocytic NF-?B activation by laquinimod protects from cuprizone-induced demyelination. Acta Neuropathol. 2012;124:411-24 pubmed publisher

Wittnam J, Portelius E, Zetterberg H, Gustavsson M, Schilling S, Koch B, et al. Pyroglutamate amyloid ? (A?) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease. J Biol Chem. 2012;287:8154-62 pubmed publisher